The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Groves Regina E since 2016.
This trader's CIK number is 1653877.
At the time of last reporting, Groves Regina E was the Director of Atricure, Inc.. (stock ticker symbol ATRC).
Also see all insider trading activities at Atricure, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ATRC | 34 | $2,607 | 3,156 | $235,847 | 0 | $0 |
| 2020 | ATRC | 0 | $0 | 6,313 | $264,072 | 0 | $0 |
| 2019 | ATRC | 500 | $12,430 | 0 | $0 | 0 | $0 |
| 2018 | ATRC | 1,000 | $17,430 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | RVA.AX | 9,815 | $15,016 | 0 | $0 | 0 | $0 |
| 2017 | RVA.AX | 1,498 | $9,094 | 0 | $0 | 0 | $0 |
| 2016 | RVA.AX | 3,608 | $27,952 | 0 | $0 | 0 | $0 |
2. Reva Medical, Inc. (RVA.AX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-04-30 | ATRC | Buy | 34 | 76.68 | 2,607 |
| 2021-09-15 | ATRC | Sale | 3,156 | 74.73 | 235,847 |
| 2020-09-14 | ATRC | Sale | 6,313 | 41.83 | 264,072 |
| 2019-09-12 | ATRC | Buy | 500 | 24.86 | 12,430 |
| 2018-03-01 | ATRC | Buy | 1,000 | 17.43 | 17,430 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-06-29 | RVA.AX | Buy | 9,815 | 1.53 | 15,016 |
| 2017-08-29 | RVA:AX | Buy | 386 | 6.37 | 2,458 |
| 2017-08-23 | RVA:AX | Buy | 407 | 6.37 | 2,592 |
| 2017-08-17 | RVA:AX | Buy | 303 | 5.57 | 1,687 |
| 2017-08-21 | RVA:AX | Buy | 402 | 5.86 | 2,357 |
| 2016-07-15 | RVA:AX | Buy | 2,683 | 7.45 | 19,996 |
| 2016-03-30 | RVA:AX | Buy | 925 | 8.60 | 7,956 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Groves Regina E (Director of Atricure, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.